98%
921
2 minutes
20
Objectives: Pancreatic diffusion-weighted imaging (DWI) has numerous clinical applications, but conventional single-shot methods suffer from off resonance-induced artifacts like distortion and blurring while cardiovascular motion-induced phase inconsistency leads to quantitative errors and signal loss, limiting its utility. Multishot DWI (msDWI) offers reduced image distortion and blurring relative to single-shot methods but increases sensitivity to motion artifacts. Motion-compensated diffusion-encoding gradients (MCGs) reduce motion artifacts and could improve motion robustness of msDWI but come with the cost of extended echo time, further reducing signal. Thus, a method that combines msDWI with MCGs while minimizing the echo time penalty and maximizing signal would improve pancreatic DWI. In this work, we combine MCGs generated via convex-optimized diffusion encoding (CODE), which reduces the echo time penalty of motion compensation, with deep learning (DL)-based denoising to address residual signal loss. We hypothesize this method will qualitatively and quantitatively improve msDWI of the pancreas.
Materials And Methods: This prospective institutional review board-approved study included 22 patients who underwent abdominal MR examinations from August 22, 2022 and May 17, 2023 on 3.0 T scanners. Following informed consent, 2-shot spin-echo echo-planar DWI (b = 0, 800 s/mm 2 ) without (M0) and with (M1) CODE-generated first-order gradient moment nulling was added to their clinical examinations. DL-based denoising was applied to the M1 images (M1 + DL) off-line. ADC maps were reconstructed for all 3 methods. Blinded pair-wise comparisons of b = 800 s/mm 2 images were done by 3 subspecialist radiologists. Five metrics were compared: pancreatic boundary delineation, motion artifacts, signal homogeneity, perceived noise, and diagnostic preference. Regions of interest of the pancreatic head, body, and tail were drawn, and mean ADC values were computed. Repeated analysis of variance and post hoc pairwise t test with Bonferroni correction were used for comparing mean ADC values. Bland-Altman analysis compared mean ADC values. Reader preferences were tabulated and compared using Wilcoxon signed rank test with Bonferroni correction and Fleiss κ.
Results: M1 was significantly preferred over M0 for perceived motion artifacts and signal homogeneity ( P < 0.001). M0 was significantly preferred over M1 for perceived noise ( P < 0.001), but DL-based denoising (M1 + DL) reversed this trend and was significantly favored over M0 ( P < 0.001). ADC measurements from M0 varied between different regions of the pancreas ( P = 0.001), whereas motion correction with M1 and M1 + DL resulted in homogeneous ADC values ( P = 0.24), with values similar to those reported for ssDWI with motion correction. ADC values from M0 were significantly higher than M1 in the head (bias 16.6%; P < 0.0001), body (bias 11.0%; P < 0.0001), and tail (bias 8.6%; P = 0.001). A small but significant bias (2.6%) existed between ADC values from M1 and M1 + DL.
Conclusions: CODE-generated motion compensating gradients improves multishot pancreatic DWI as interpreted by expert readers and eliminated ADC variation throughout the pancreas. DL-based denoising mitigated signal losses from motion compensation while maintaining ADC consistency. Integrating both techniques could improve the accuracy and reliability of multishot pancreatic DWI.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/RLI.0000000000001148 | DOI Listing |
Eur J Nucl Med Mol Imaging
September 2025
Department of Nuclear Medicine, Changhai Hospital, Naval Medical University, 168 Changhai Road, Yang Pu District, Shanghai, 200433, China.
Purpose: In this retrospective study, whether [Ga]Ga-DOTA-FAPI-04 PET/MR imaging biomarkers can predict the progression-free survival (PFS) and overall survival (OS) of patients with advanced pancreatic cancer was investigated.
Methods: Fifty-one patients who underwent [Ga]Ga-DOTA-FAPI-04 PET/MR scans before first-line chemotherapy were recruited. Imaging biomarkers, including the maximum tumor diameter, minimum apparent diffusion coefficient (ADC), maximum and mean standardized uptake values (SUV and SUV), fibroblast activation protein- (FAP-) positive tumor volume (FTV and W-FTV) and total lesion FAP expression (TLF and W-TLF), were recorded for primary and whole-body tumors.
Skeletal Radiol
September 2025
Department of Radiology, Federal University of Sao Paulo (UNIFESP), Napoleão de Barros St, 800, São Paulo, SP, 04024-000, Brazil.
Objective: To evaluate multiparametric MRI features of pediatric soft-tissue sarcomas, comparing pre-treatment and post-treatment features, and assessing correlation with clinical outcomes.
Materials And Methods: Retrospective cohort study, including pediatric patients (≤ 18 years) with histologically-confirmed soft-tissue sarcomas who underwent MRI with anatomic and functional sequences in consecutive series. Post-treatment MRI was available for a subset, and features were recorded by two readers.
J Neuroradiol
September 2025
Department of Neuroradiology, East Group Hospital, Hospices Civils de Lyon. 59 Bd Pinel, 69500, Bron, France; CREATIS Laboratory, CNRS UMR 5220, INSERM U1294, Claude Bernard Lyon I University. 7 avenue Jean Capelle O, 69100, Villeurbanne, France. Electronic address:
Background: Distinguishing radiation necrosis (RN) from true progression (TP) in irradiated brain metastases is challenging. We evaluated the diagnostic performance of the centrally restricted diffusion sign on diffusion-weighted imaging (DWI).
Methods: From August 2014 to August 2024, we screened 321 patients with histologically confirmed brain metastases treated with radiation therapy and follow-up MRI for new or enlarging necrotic lesions ≥1 cm.
Eur Radiol
September 2025
Department of Pathology, Bicêtre Hospital, AP-HP University Paris Saclay, Le Kremlin-Bicêtre, France.
Objectives: The aim of this study was to describe the imaging features on dynamic CT and MRI of a series of pathologically confirmed low-grade vascular neoplasia of the liver (LGVNL).
Materials And Methods: In this retrospective multicenter study, patients diagnosed with pathologically proven LGVNL between January 2014 and August 2024 and with cross-sectional imaging (CT or MRI) were included. Based on prior studies, we divided the patients into two groups: a group with typical LGVNL features and a group with atypical tumors.
Pol J Radiol
July 2025
University of Health Sciences, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Türkiye.
Purpose: The purpose of this study was to determine the effectiveness of ADC histogram analysis in diagnosing and determining the aggressiveness of peripheral zone (PZ) prostate cancer, and to reveal the relationship between Gleason and PI-RADS scores.Material and method: 61 patients who underwent standard 12-core and cognitive prostate biopsy and multiparametric prostate magnetic resonance imaging before biopsy were included in the study. According to the pathology results, patients were classified as either having clinically significant cancer with malignancy ( = 35) or as clinically insignificant - benign ( = 26).
View Article and Find Full Text PDF